Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAMIP
Original Assignee
SAMIP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAMIPfiledCriticalSAMIP
Priority to FR7020300ApriorityCriticalpatent/FR2092632A1/en
Publication of FR2092632A1publicationCriticalpatent/FR2092632A1/en
Application grantedgrantedCritical
Publication of FR2092632B1publicationCriticalpatent/FR2092632B1/fr
Cpds. of formula:- (where R is alkyl, alkoxy, NO2, CF3 or halogen; n = 1, 2 or 3. Preferred is (I) (R = 2-Cl). The cpds. are diuretics with low toxicity. (I) (R = 2-cl) has 100 times the diuretic activity (in the rat) of chlorothiazide. Prepared conventionally from a benzolylhydrazine and 4-chloro-3-sulphamoylbenzoyl chloride.
FR7020300A1970-06-031970-06-03N-(4-chloro-3-sulphamoyl) benzoyl-n'-benzoylhydrazines - - with diuretic activity
GrantedFR2092632A1
(en)